{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:53:22Z","timestamp":1761562402205,"version":"3.41.2"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR002378","TL1 TR00238"],"award-info":[{"award-number":["UL1 TR002378","TL1 TR00238"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>HIV treatment with tenofovir alafenamide fumarate (TAF) has decreased renal toxicity compared with tenofovir disoproxil fumarate in clinical trials. We report the case of a patient with HIV\/HCV coinfection who was started on a TAF-based HIV regimen and developed acute kidney injury that worsened with the addition of sofosbuvir-ledipasvir.<\/jats:p>","DOI":"10.1093\/ofid\/ofy189","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T04:29:27Z","timestamp":1532924967000},"source":"Crossref","is-referenced-by-count":15,"title":["Acute Kidney Injury in a Patient on Tenofovir Alafenamide Fumarate After Initiation of Treatment for Hepatitis C Virus Infection"],"prefix":"10.1093","volume":"5","author":[{"given":"David P","family":"Serota","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold A","family":"Franch","sequence":"additional","affiliation":[{"name":"Atlanta VA Medical Center, Veterans Health Administration, Atlanta, Georgia"},{"name":"Division of Renal Medicine, Department of Medicine, Emory University, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily J","family":"Cartwright","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia"},{"name":"Atlanta VA Medical Center, Veterans Health Administration, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"key":"2020081004293518900_CIT0001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/M13-1829","article-title":"Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study","volume":"160","author":"Lo Re","year":"2014","journal-title":"Ann Intern Med"},{"key":"2020081004293518900_CIT0002","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1086\/644771","article-title":"Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression","volume":"49","author":"Chen","year":"2009","journal-title":"Clin Infect Dis"},{"author":"AASLD-IDSA","key":"2020081004293518900_CIT0003"},{"key":"2020081004293518900_CIT0004","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa1501315","article-title":"Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1","volume":"373","author":"Naggie","year":"2015","journal-title":"N Engl J Med"},{"key":"2020081004293518900_CIT0005","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/cid\/cix111","article-title":"Effectiveness of All-oral antiviral regimens in 996 human immunodeficiency virus\/hepatitis C virus genotype 1-coinfected patients treated in routine practice","volume":"64","author":"Bhattacharya","year":"2017","journal-title":"Clin Infect Dis"},{"volume-title":"Harvoni (Ledipasvir And Sofosbuvir) [package insert]","year":"2017","key":"2020081004293518900_CIT0006"},{"key":"2020081004293518900_CIT0007","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/hiv.12401","article-title":"The role of tenofovir alafenamide in future HIV management","volume":"17","author":"Antela","year":"2016","journal-title":"HIV Med"},{"key":"2020081004293518900_CIT0008","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/QAI.0000000000001350","article-title":"Brief report: randomized, double-blind comparison of tenofovir alafenamide (TAF) vs tenofovir disoproxil fumarate (TDF), each coformulated with elvitegravir, cobicistat, and emtricitabine (E\/C\/F) for initial HIV-1 treatment: week 144 results","volume":"75","author":"Arribas","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020081004293518900_CIT0009","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(15)60616-X","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials","volume":"385","author":"Sax","year":"2015","journal-title":"Lancet"},{"key":"2020081004293518900_CIT0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/hiv.12468","article-title":"Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients","volume":"18","author":"Hoffmann","year":"2017","journal-title":"HIV Med"},{"key":"2020081004293518900_CIT0011","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1002\/phar.1803","article-title":"Nephrotoxicity associated with concomitant use of ledipasvir-sofosbuvir and tenofovir in a patient with hepatitis C virus and human immunodeficiency virus coinfection","volume":"36","author":"Bunnell","year":"2016","journal-title":"Pharmacotherapy"},{"key":"2020081004293518900_CIT0012"},{"key":"2020081004293518900_CIT0013","article-title":"Incidence of acute kidney injury in patients coinfected with HIV and hepatitis C virus receiving tenofovir disoproxil fumarate and ledipasvir\/sofosbuvir in a real-world, urban, Ryan White clinic","author":"Michal","year":"","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2020081004293518900_CIT0014","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.ajkd.2011.01.022","article-title":"Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence","volume":"57","author":"Hall","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"2020081004293518900_CIT0015","doi-asserted-by":"crossref","first-page":"e8046","DOI":"10.1097\/MD.0000000000008046","article-title":"Tenofovir alafenamide nephrotoxicity in an HIV-positive patient: a case report","volume":"96","author":"Novick","year":"2017","journal-title":"Medicine"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/8\/ofy189\/33577269\/ofy189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/8\/ofy189\/33577269\/ofy189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T02:58:59Z","timestamp":1751770739000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofy189\/5061248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofy189","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,7,30]]},"article-number":"ofy189"}}